ekonominyheter

TranslateRSSMobil
India Drug Maker Asked to Revise $3.2 Billion Merger Plan

India Drug Maker Asked to Revise $3.2 Billion Merger Plan

Wall Street Journal 14/11 06:47

India?s antitrust regulator has asked drug maker Sun Pharmaceutical Industries Ltd. to rework its $3.2 billion proposed merger with Ranbaxy Laboratories Ltd.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status